Melatonin--a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro.
about
Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.Redox Modulations, Antioxidants, and Neuropsychiatric DisordersCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesMelatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsMelatonin in Alzheimer's disease and other neurodegenerative disordersMitochondrial function in hypoxic ischemic injury and influence of agingCellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disordersSleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes.A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Effect of photoperiod on the feline adipose transcriptome as assessed by RNA sequencing.The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injuryOrally administered melatonin prevents lipopolysaccharide-induced neural tube defects in mice.Reactive oxygen species in the regulation of synaptic plasticity and memory.Strategies for reducing or preventing the generation of oxidative stressThe fetal origins of the metabolic syndrome: can we intervene?Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.Alleviating effects of melatonin on oxidative changes in the testes and pituitary glands evoked by subacute chlorpyrifos administration in Wistar ratsNeuroprotective effect of acute melatonin treatment on hippocampal neurons against irradiation by inhibition of caspase-3The Protective Effects of Exogenous Melatonin on Nicotine-induced Changes in Mouse Ovarian Follicles.Hepatoprotective actions of melatonin: possible mediation by melatonin receptorsNew evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide.The anti-inflammatory effect of erythropoietin and melatonin on renal ischemia reperfusion injury in male ratsCombination antioxidant effect of erythropoietin and melatonin on renal ischemia-reperfusion injury in rats.Effects of melatonin on partial unilateral ureteral obstruction induced oxidative injury in rat kidneyLong sleep duration and frequent day-time naps of the infants can be protective for vigabatrin-induced visual field defects.Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion.Cerebral ischemia and neuroregeneration.A Possible Role for Singlet Oxygen in the Degradation of Various Antioxidants. A Meta-Analysis and Review of Literature Data.Effect of exogenous melatonin and different photoperiods on oxidative status and antioxidant enzyme activity in Chhotanagpuri ewe.Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
P2860
Q24815611-52C29B50-5E2A-443E-B293-838E4FA5100FQ26774067-744C0752-8CFF-4BEA-9F9D-F1547C519804Q27002459-FA70D35E-96A9-4847-9FEA-07B4654E1A6BQ28075345-8A244E1E-3E79-4982-95D2-045D63348136Q28217483-94038227-7020-4E97-BCA4-0E4F9D8FC484Q28396663-7C1B6B95-7E83-413A-BA80-B673108A2C0BQ28754228-EED151CD-72AA-4E96-A400-76FE8B8CB2BAQ30823493-C947D9BE-9931-4A98-9C88-DD72F447CC3AQ30981817-2B3282DE-843D-49B7-B36E-A2CBB7FEEC57Q33624824-CAC17BCB-5D72-42BA-8AF1-EA018D614CCFQ33883437-C8835351-1C39-4C6C-9E96-4CBBA5F6D687Q34003451-97C006AD-35D2-4A52-8760-DE00435DB7AFQ34566276-6D030465-0E78-4A7F-BFF0-7104BA61D0F6Q34805998-923BE383-5434-4611-9B26-2C77847E5AA2Q35609538-5B30C0E4-9DCD-4AD9-B492-AB76EE2706E7Q36277582-B5F56E2E-4387-4EA9-9422-4E5BBCC4F2DEQ36283905-3156A959-0F96-49D9-8737-0F72DC5A1F18Q36719869-E051B901-7376-41B7-85E2-5367C7C7367FQ36954056-33AB061E-D766-4597-A826-44EA04076073Q37035338-D6CBA045-6160-464A-9510-776A6542345FQ37823548-2CD21139-A715-49AA-8B50-7544E5FF09F2Q39140519-E8D4CBFA-2EFD-46C2-A723-F6B4401159E8Q41859941-BC8153B4-7014-4C0C-89B7-67EE1D7C013EQ41975960-0F2FA47F-F50F-4F14-A68A-5969D123E9C0Q42104822-DBE53DCF-8954-44C7-93B5-C216A5C13D94Q42794687-1F12256D-D0CA-4C93-8645-C6704DAB536EQ47146884-59FDD27C-3E4E-42CD-B69B-5F0BB0ACF27DQ52603055-A389F044-9216-4E61-84C6-928BE5A15A79Q52679073-AD34E467-BF13-4317-93B3-A29DF17541B6Q55165480-ACF20ECD-B5EC-4817-BDEB-787250EB2477Q58766687-5E5B996E-7046-40C4-8B7E-A7D7C281C1AA
P2860
Melatonin--a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Melatonin--a highly potent end ...... this indole accessed in vitro.
@ast
Melatonin--a highly potent end ...... this indole accessed in vitro.
@en
Melatonin--a highly potent end ...... this indole accessed in vitro.
@nl
type
label
Melatonin--a highly potent end ...... this indole accessed in vitro.
@ast
Melatonin--a highly potent end ...... this indole accessed in vitro.
@en
Melatonin--a highly potent end ...... this indole accessed in vitro.
@nl
prefLabel
Melatonin--a highly potent end ...... this indole accessed in vitro.
@ast
Melatonin--a highly potent end ...... this indole accessed in vitro.
@en
Melatonin--a highly potent end ...... this indole accessed in vitro.
@nl
P2093
P1476
Melatonin--a highly potent end ...... this indole accessed in vitro.
@en
P2093
Barlow-Walden LR
Manchester LC
Poeggeler B
P304
P407
P577
1994-11-01T00:00:00Z